Logo-jpd
J Parathyr Dis. 2018;6(2): 72-73.
doi: 10.15171/jpd.2018.22
  Abstract View: 5054
  PDF Download: 1791

Commentary

Magnesium and parathyroid hormone among end-stage renal disease patients

Seyed Seifollah Beladi Mousavi, Fatemeh Hayati, Shokouh Shayanpour, Shahla Ahmadi Halili*

1 Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
*Corresponding Author: *Corresponding author: Shahla Ahmadi Halili,, Email: Ahmadihalili@gmail.com

Abstract

Implication for health policy/practice/research/medical educationHypermagnesemia is also not a prominent feature among patients with chronic kidney disease, in the absence of increased magnesium administration, however renal failure mostly at its final stages is most common cause of hypermagnesemia.

Implication for health policy/practice/research/medical educationHypermagnesemia is also not a prominent feature among patients with chronic kidney disease, in the absence of increased magnesium administration, however renal failure mostly at its final stages is most common cause of hypermagnesemia.
First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.


Full Text View:

Your browser does not support the canvas element.